Chapter 2953: The core technology cannot be made public!
…
"Therefore, how to use this technology still requires us to communicate and cooperate with relevant medical institutions and expert teams to jointly promote the application of this technology in more regions and countries and restore sight to more blind patients."
In fact, there is one thing Wu Hao did not mention, that is, this artificial cornea bio-3D printing system and biological cell cloning cultivation system are important controlled technologies and are strictly confidential and cannot be sold to the outside world.
Even in order to prevent technology leaks, many of these key core technologies have not applied for patents. Once applied for a patent, it means that the technology must be disclosed, and disclosure is exchanged for protection. This is the core of patent law.
But this has brought about a problem, that is, many countries do not recognize international patents, especially those involving major patented technologies related to the country and society and people's livelihood. These countries often do not recognize them.
For example, Sanguo, why are their generic drugs so widespread and so cheap? This is because they do not recognize international patent laws, so this has led to the proliferation of domestic preventive drugs.
How can I describe this behavior? There are advantages and disadvantages. The advantage is that you can obtain advanced foreign technology at a very cheap price, which is very cost-effective. For example, for many important drugs, some pharmaceutical giants sell a bottle for tens of thousands.
But in Sanguo, it only costs a few hundred yuan.
Therefore, this method allows many people to benefit from it and obtain high-quality medical resources at cheap prices.
But the same disadvantages are also very obvious. First of all, the behavior of Sanguo has been criticized internationally. It is essentially a kind of banditry and is not conducive to the development and innovation of technology.
In addition, Sanguo's conniving approach has also greatly affected or even destroyed Sanguo's domestic scientific research and innovation capabilities, causing its scientific research and innovation capabilities to lose the soil for innovation, and its scientific and technological development level will be greatly lagging behind.
Finally, there is retaliation and counterattack from other countries and pharmaceutical companies. For example, some advanced pharmaceutical products and technologies will not choose to enter the country. And some new technologies emerging in the country will also receive equal treatment in the country.
, cannot get the protection it deserves.
This is also the reason why countries are fighting so fiercely over intellectual property rights, but they don’t dare to think about it, because it is a way of hurting others by a thousand and hurting yourself eight hundred.
In addition, when some technology patents involve national security, they may also be directly invalidated. This situation has been very common in recent years, especially some gangsters, under the guise of national security, unscrupulously began to undermine relevant laws and rules.
.
And this is still in a relatively peaceful and stable period. Once a war breaks out, these so-called laws will become invalid and have no effect.
Therefore, any major core technologies that are involved will generally not directly apply for patents. Haoyu Technology's biological 3D printing system and biological cell cloning and cultivation system are strategic-level technology products, both for society and the country.
It plays a very important role, so the core technology is of course impossible to leak.
In order to prevent others from copying, and also to prevent others from registering relevant technology patents first, which would in turn tie Wu Hao's neck, they will apply for a lot of peripheral patented technologies, which is often called a patent moat plan. Utilize many
Peripheral technology patents are used to set up patent barriers to ensure that core technologies will not be infringed.
Of course, according to Wu Hao's business strategy and confidentiality needs, their biological 3D printing system and biological cell cloning cultivation system will not be sold to the outside world. They will direct the establishment of relevant biological laboratories to open them to the outside world and accept relevant information.
Order.
This is actually similar to the porcelain tooth customization plan in the dental field. The hospital issues a request to provide relevant data, and then it is handed over to the factory for customized production.
The same is true for the biological laboratory. The hospital makes an application and provides the patient's relevant cell tissue in accordance with relevant requirements, and then sends it to the biological laboratory for printing. After the printing is completed, it will be sent back to the hospital for surgical transplantation as soon as possible.
In this way, the pressure on the hospital and patients can be reduced. The hospital does not need to spend so much money to buy such a set of equipment for its own printing. It also does not need to spread the cost of buying equipment equally to each patient, which greatly improves the efficiency of printing.
It reduces the cost of treatment for patients.
In addition, neither patients, hospitals, nor others have access to these devices, so technology confidentiality can be better maintained and core technologies can be prevented from being leaked.
Speaking of this, after a slight pause, Wu Hao continued to speak to Su Qian and the many reporters in the audience: "As to whether this printed artificial biological cornea is reliable and will not cause problems in long-term use, to be honest, we cannot tell the truth at the moment.
Give the answer.
Judging from the application of our bioprinted organs and tissues in the human body before, these printed organs and tissues are in good condition and function, and there are no problems.
However, it has only been a few years since this technology was applied to clinical trials, so we are still unable to determine whether the organs and tissues printed and transplanted into patients will still be in good condition and function a few years or more than ten years later.
No problems occurred.
So we understand everyone's concerns. But you don't have to worry too much. At least its status and functions will still be very good within a few years, and there will be no problems.
We can't say whether there will be problems with these organs and tissues in five or six years or more than ten years. But you don't have to worry too much. As long as you perform normal physical examinations, there will be no problems.
Let’s take a step back and say that if there are problems in the future in constructing the organs and tissues in these transplant patients, then it doesn’t matter. Since one transplant can be completed, then the second transplant can be completed, and then it will be better to re-transplant.
.
If some diseases may not allow for a second transplant, then I think there is no need to regret. After all, using this technology, we have saved and extended the lives of patients for a lot of time, or brought a lot of convenience to patients.
.I believe that even if problems do arise in the future, the patients and their families will understand and will not regret today's choices and decisions.
Of course, we also attach great importance to this issue. Before determining the treatment plan, we have fully communicated with the patient and the patient's family to ensure that they have sufficient information before making choices and decisions. And the entire conversation
Lawyers were present throughout the signing process and video recording was conducted to ensure that there would be no misunderstandings or disputes in the future."